MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 24.02.2026
Myriad Genetics Anteile 2011-2026 | MYGN
Anteile Jährlich Myriad Genetics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92.6 M | 90.6 M | 82.8 M | 81.2 M | 80 M | 75.4 M | 73.5 M | 69.4 M | 68.3 M | 70 M | 71.3 M | 75.7 M | 80.9 M | 84.6 M | 89.8 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 92.6 M | 68.3 M | 79.1 M |
Anteile Vierteljährlich Myriad Genetics
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93.1 M | 92.5 M | 91.3 M | 90.9 M | 90.6 M | 89.9 M | 89.9 M | 81.9 M | 81.7 M | 81.3 M | 81.2 M | 80.7 M | 80.4 M | 80.1 M | 80 M | 78.8 M | 77.2 M | 76 M | 75.4 M | 74.7 M | 74.6 M | 74.7 M | 74.4 M | 73.7 M | 74.4 M | 73.7 M | 74.2 M | 73 M | 74.2 M | 73 M | 69.3 M | 68.6 M | 69.3 M | 68.6 M | 68.2 M | 68.8 M | 68.2 M | 68.8 M | 70.5 M | 68.7 M | 70.5 M | 68.7 M | 72.5 M | 72.8 M | 72.5 M | 72.8 M | 75.1 M | 79.6 M | 75.1 M | 79.6 M | 81.7 M | 81.6 M | 81.7 M | 81.6 M | 84.5 M | 85.2 M | 84.5 M | 85.2 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 93.1 M | 68.2 M | 77.6 M |
Anteile anderer Aktien in der Diagnostik & Forschung
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
304 M | $ 113.25 | -1.38 % | $ 34.4 B |  USA |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 17.42 | -2.24 % | $ 928 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 16.35 | 0.28 % | $ 172 M |  China |
 |
Co-Diagnostics
CODX
|
1.33 M | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Danaher Corporation
DHR
|
713 M | $ 189.05 | -1.58 % | $ 135 B | USA |
 |
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
DexCom
DXCM
|
390 M | $ 63.32 | 0.17 % | $ 24.7 B | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 166.89 | -0.79 % | $ 8.27 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Castle Biosciences
CSTL
|
27.8 M | $ 24.75 | 0.08 % | $ 687 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
|
Biodesix
BDSX
|
130 M | $ 14.37 | -6.48 % | $ 1.86 B | USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 15.98 | -2.68 % | $ 483 M | USA |
 |
Guardant Health
GH
|
125 M | $ 90.17 | 0.56 % | $ 11.3 B | USA |
 |
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
32.5 K | $ 2.61 | 0.58 % | $ 84.7 K | USA |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 107.87 | -1.6 % | $ 8.9 B |  Irlanda |
 |
Illumina
ILMN
|
159 M | $ 126.04 | -1.33 % | $ 20 B | USA |
 |
Biomerica
BMRA
|
2.3 M | $ 2.13 | -1.84 % | $ 4.89 M | USA |
 |
BioNano Genomics
BNGO
|
5.44 M | $ 1.15 | -0.43 % | $ 6.26 M | USA |
 |
Interpace Biosciences
IDXG
|
4.42 M | $ 1.98 | 0.51 % | $ 8.76 M | USA |
 |
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M |  Israel |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 271.93 | -0.96 % | $ 22.6 B | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 76.19 | 0.4 % | $ 5.14 B | USA |
 |
Celcuity
CELC
|
46.8 M | $ 113.92 | -0.26 % | $ 5.33 B | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 501.47 | 1.1 % | $ 14.5 B | USA |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
NeoGenomics
NEO
|
128 M | $ 7.9 | -1.5 % | $ 1.01 B | USA |
 |
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | USA |
 |
Neogen Corporation
NEOG
|
217 M | $ 9.93 | 3.82 % | $ 2.15 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 198.9 | -0.08 % | $ 22.1 B | USA |
 |
National Research Corporation
NRC
|
22.4 M | $ 17.07 | -1.5 % | $ 382 M | USA |
 |
Natera
NTRA
|
98.4 M | $ 206.47 | 0.78 % | $ 20.3 B | USA |
 |
ENDRA Life Sciences
NDRA
|
787 K | $ 4.71 | -0.74 % | $ 3.71 M | USA |
 |
Pacific Biosciences of California
PACB
|
300 M | $ 1.42 | - | $ 426 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
904 M | $ 26.78 | -1.58 % | $ 20 B | Niderland |
 |
Precipio
PRPO
|
1.61 M | $ 26.03 | 0.19 % | $ 41.8 M | USA |
 |
Personalis
PSNL
|
59.3 M | $ 6.03 | -8.36 % | $ 357 M | USA |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |